清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register

肢端肥大症 医学 垂体瘤 内科学 入射(几何) 放射治疗 儿科 激素 生长激素 内分泌学 光学 物理
作者
Steinunn Arnardóttir,Jacob Järås,Pia Burman,Katarina Berinder,Per Dahlqvist,Eva Marie Erfurth,Charlotte Höybye,Karin Larsson,Oskar Ragnarsson,Bertil Ekman,Britt Edén Engström
出处
期刊:European journal of endocrinology [Oxford University Press]
卷期号:186 (3): 329-339 被引量:12
标识
DOI:10.1530/eje-21-0729
摘要

To describe the treatment and long-term outcomes of patients with acromegaly from all healthcare regions in Sweden.Analysis of prospectively reported data from the Swedish Pituitary Register of 698 patients (51% females) with acromegaly diagnosed from 1991 to 2011. The latest clinical follow-up date was December 2012, while mortality data were collected for 28.5 years until June 2019.The annual incidence was 3.7/million; 71% of patients had a macroadenoma, 18% had visual field defects, and 25% had at least one pituitary hormone deficiency. Eighty-two percent had pituitary surgery, 10% radiotherapy, and 39% medical treatment. At the 5- and 10-year follow-ups, insulin-like growth factor 1 levels were within the reference range in 69 and 78% of patients, respectively. In linear regression, the proportion of patients with biochemical control including adjuvant therapy at 10 years follow-up increased over time by 1.23% per year. The standardized mortality ratio (SMR) (95% CI) for all patients was 1.29 (1.11-1.49). For patients with biochemical control at the latest follow-up, SMR was not increased, neither among patients diagnosed between 1991 and 2000, SMR: 1.06 (0.85-1.33) nor between 2001 and2011, SMR: 0.87 (0.61-1.24). In contrast, non-controlled patients at the latest follow-up from both decades had elevated SMR, 1.90 (1.33-2.72) and 1.98 (1.24-3.14), respectively.The proportion of patients with biochemical control increased over time. Patients with biochemically controlled acromegaly have normal life expectancy, while non-controlled patients still have increased mortality. The high rate of macroadenomas and unchanged age at diagnosis illustrates the need for improvements in the management of patients with acromegaly.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健应助甜甜的金鑫采纳,获得10
2秒前
4秒前
11秒前
15秒前
量子星尘发布了新的文献求助10
41秒前
49秒前
Sunny完成签到,获得积分10
53秒前
三年三班三井寿完成签到,获得积分10
1分钟前
1分钟前
量子星尘发布了新的文献求助10
1分钟前
oleskarabach完成签到,获得积分20
1分钟前
oleskarabach发布了新的文献求助10
2分钟前
2分钟前
华仔应助科研通管家采纳,获得10
2分钟前
2分钟前
糯米糍发布了新的文献求助10
2分钟前
SYLH应助oleskarabach采纳,获得10
2分钟前
yingying完成签到,获得积分20
2分钟前
2分钟前
小蘑菇应助古月采纳,获得10
3分钟前
领导范儿应助Mr采纳,获得10
3分钟前
naczx完成签到,获得积分0
3分钟前
3分钟前
Mr发布了新的文献求助10
3分钟前
3分钟前
古月发布了新的文献求助10
3分钟前
量子星尘发布了新的文献求助10
3分钟前
下午好完成签到 ,获得积分10
3分钟前
003完成签到,获得积分10
3分钟前
zzhui完成签到,获得积分10
3分钟前
3分钟前
黑球发布了新的文献求助10
3分钟前
xiaozou55完成签到 ,获得积分10
3分钟前
4分钟前
黑球完成签到,获得积分10
4分钟前
4分钟前
不是山谷完成签到,获得积分10
4分钟前
4分钟前
5分钟前
逺山長发布了新的文献求助10
5分钟前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A new approach to the extrapolation of accelerated life test data 500
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3953501
求助须知:如何正确求助?哪些是违规求助? 3498943
关于积分的说明 11093377
捐赠科研通 3229545
什么是DOI,文献DOI怎么找? 1785524
邀请新用户注册赠送积分活动 869430
科研通“疑难数据库(出版商)”最低求助积分说明 801462